Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01106872
Title Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Iowa
Indications

sarcoma

Therapies

Bevacizumab + Docetaxel + Gemcitabine + Valproic acid

Age Groups: adult
Covered Countries USA


No variant requirements are available.